Overview / Abstract: |
Target Audience This educational activity is directed toward rheumatologists, specialty nurse practitioners, specialty physician assistants, family physicians/primary care physicians, and additional health care providers involved in the treatment and management of patients with RA. Activity Overview This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of rheumatoid arthritis (RA), with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of disease diagnosis, current and emerging treatment strategies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Analyze the pathophysiologic underpinnings of rheumatoid arthritis (RA), and understand the importance of early diagnosis as it relates to QoL |
Expiration |
Nov 16, 2021 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.50 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Vibeke Strand, MD, MACR, FACP Jon T. Giles, MD, MPH |
Sponsors / Supporters / Grant Providers |
Sanofi Genzyme |
Keywords / Search Terms |
Relias LLC FREE CME, Relias LLC., RA Management Free CE CME |